Clearance of bacterial lipopolysaccharides and lipid A by the liver and the role of argininosuccinate synthase

Innate Immunity

Volumn 14, Issue 1, 2008, Pages 51-60

  Satoh, Motonobu ^a   Ando, Shingo ^a   Shinoda, Takehiro ^a   Yamazaki, Masatoshi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Argininosuccinate synthase; Clearance; Endotoxin; Lipid A; Liver

Indexed keywords

ARGININOSUCCINATE SYNTHASE; BACTERIUM LIPOPOLYSACCHARIDE; CARBON TETRACHLORIDE; DEXAMETHASONE; GLUCAGON; LIPID A; O ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CLEARANCE; CONTROLLED STUDY; CULTURE MEDIUM; DETOXIFICATION; ENZYME ACTIVITY; HEPATITIS; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER FAILURE; LIVER METABOLISM; LIVER TOXICITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN CONTENT; STRAIN DIFFERENCE; LIVER CLEARANCE; SPHEROID CELL;

BACTERIA (MICROORGANISMS); MUS;

EID: 59649095366     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425907087267     Document Type: Article

References (31)

1. Nowotny A. Review of molecular requirements of endotoxic reactions. Rev Infect Dis 1987; 9: 503-511.
2. Morrison DC, Ryan JL Bacterial endotoxin and host immune response. Adv Immunol 1983; 28: 293-452.
3. Kitchens RL, Munford RS CD14-dependent-internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS. J Immunol 1998; 160: 1920-1928.
4. Gegner JA, Ulevitch RJ, Tobias PS Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995; 270: 5320-5325.
5. Hewett JA, Roth RA Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev 1993; 45: 382-411.
6. Harris HW, Grunfeld C., Feingold KR et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993; 91: 1028-1034.
7. Harris HW, Brady SE, Rapp JH Hepatic endosomal trafficking of lipoprotein-bound endotoxin in rats. Surg Res 2002; 106: 188-195.
8. Macintire DK, Bellhorn TL Bacterial translocation: Clinical implications and prevention. Vet Clin North Am Small Anim Pract 2002; 32: 1165-1178.
9. Lichtman SM Bacterial translocation in humans. J Pediatr Gastroenterol Nutr 2001; 33: 1-10.
10. Reynolds JV, Murchan P., Leonard N. et al. Gut barrier failure in experimental obstructive jaundice. J Surg Res 1996; 62: 11-16.
11. Kakkos SK, Kirkilesis J., Scopa CD et al. Nonabsorbable antibiotics reduce bacterial and endotoxin translocation in hepatectomised rats. HPB Surg 1997; 10: 283-289.
12. Hori Y., Takeyama Y., Ueda T. et al. Impaired transport of lipopolysaccharide across the hepatocytes in rats with ceruleininduced experimental pancreatitis. Pancreas 1998; 16: 148-153.
13. Satoh M., Iwahori T., Sugawara N., Yamazaki M. Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activities. J Endotoxin Res 2006; 12: 21-38.
14. Husson A., Brasse-Lagnel C., Fairand A. et al. Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem 2003; 270: 1887-1899.
15. Saheki T., Komorizono K., Miura T. et al. Clearance of argininosuccinate synthetase from the circulation in acute liver disease. Clin Biochem 1990; 23: 139-141.
16. Satoh M., Adachi K., Suda T. et al. TNF-driven inflammation during mouse liver regeneration after partial hepatectomy and its role in growth regulation of liver. Mol Biother 1991; 3: 136-147.
17. Satoh M., Matsumura T., Nakamoto M., Yamazaki M. Inhibition of TNF-triggering activity of lipopolysaccharide by a proteinaceous factor from normal mouse liver extract. J Immunol 1995; 155: 877-885.
18. Satoh M., Yamazaki M. Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor β and interleukin 6. J Cell Physiol 1992; 150: 134-139.
19. Satoh M., Tsurumaki K., Kagehara H., Yamazaki M. Induction of intratumoral tumor necrosis factor by a synthetic lipid A analog, ONO-4007, with less tolerance in repeated administration and its implication in potent antitumor effects with low toxicity. Cancer Immunol Immunother 2002; 50: 653-662.
20. Abu-Absi SF, Friend JR, Hansen LK, Hu WS Structural polarity and functional bile canaliculi in rat hepatocyte spheroids. Exp Cell Res 2002; 274: 56-67.
21. Lin RC, Snodgrass PJ, Rabier D. Induction of urea cycle enzymes by glucagon and dexamethasone in monolayer cultures of adult rat hepatocytes. J Biol Chem 1982; 257: 5061-5067.
22. McCay PB, Lai EK, Poyer JL et al. Oxygen and carbon centered free radical formation during carbon tetrachloride metabolism. Observation of lipid radicals in vivo and in vitro. J Biol Chem 1984; 259: 2135-2143.
23. Hasunuma R., Morita H., Tanaka S. et al. Differential clearance and induction of host responses by various administered or released lipopolysaccharides. J Endotoxin Res 2001; 7: 421-429.
24. Denlinger LC, Garis KA, Sommer JA et al. Nuclear translocation of NF-κB in lipopolysaccharide treated macrophages fails to correspond to endotoxicity: Evidence suggesting a requirement for a gammainterferon-like signal. Infect Immun 1998; 66: 1638-1647.
25. Amura CR, Silverstein R., Morrison DC Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect Immun 1998; 66: 5372-5378.
26. Rietsche ETh, Kirikae T., Schade FU et al. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 1993; 187: 169-190.
27. Kitchens RL, Munford RS CD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS. J Immunol 1998; 160: 1920-1928.
28. Iovine N., Eastvold J., Elsbach P., Weiss JP, Gioannini TL The carboxyl-terminal domain of closely related endotoxin binding proteins determines the target of protein-lipopolysaccharide complexes. J Biol Chem 2002; 277: 7970-7978.
29. Caccavo D., Afeltra A., Pece S. et al. Lactoferrin-lipidA-lipopolysaccharide interaction: Inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14. Infect Immun 1999; 67: 4668-4672.
30. Li CM, Chao HK, Liu YF, Su TS A nonsense mutation is responsible for the RNA-negative phenotype in human citrullinaemia. Eur J Hum Genet 2001; 9: 685-689.
31. Yoshino S., Sasatomi E., Mori Y., Sagai M. Oral administration of lipopolysaccharide exacerbates collagen-induced arthritis in mice. J Immunol 1999; 163: 3417-3422.